ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,423Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 192

$378K Total Retail Price of All Prescriptions

Rank: 25 out of 192

198 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in District of Columbia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 198 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 198 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
ATORVASTATIN CALCIUM 195 177 50 1 3
AMLODIPINE BESYLATE 195 174 31 1 1
SIMVASTATIN 139 118 28 3 4
LEVOTHYROXINE SODIUM 137 132* 21 4 8
LISINOPRIL 121 103 20 5 2
QUETIAPINE FUMARATE 115 115 12 A 6 47
DONEPEZIL HCL 108 108 11 7 30
MIRTAZAPINE 108 108 13 7 42
FUROSEMIDE 105 100* 13 9 7
OMEPRAZOLE 93 93 13 10 10
GABAPENTIN 91 <11 <11 11 14
VALSARTAN-HYDROCHLOROTHIAZIDE 86 74 18 12 40
ALBUTEROL SULFATE 80 80 13 13 100
LOSARTAN POTASSIUM 67 62* 13 14 9
CLONAZEPAM 65 <11 <11 B 15 91
CYMBALTA 65 <11 <11 15 101
METOPROLOL SUCCINATE 64 59* 13 17 11
TRAMADOL HCL 64 <11 <11 17 27
OLANZAPINE 62 <11 <11 A 19 102
POTASSIUM CHLORIDE 60 <11 <11 20 43
HYDROCHLOROTHIAZIDE 58 53* 11 21 5
PRAVASTATIN SODIUM 57 57 11 22 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 52* 16 22 18
CRESTOR 56 51* 14 24 16
CLOPIDOGREL 55 <11 <11 25 15
METOPROLOL TARTRATE 55 <11 <11 25 12
SERTRALINE HCL 52 <11 <11 27 36
TRAZODONE HCL 52 <11 <11 27 57
LORAZEPAM 51 <11 <11 B 29 70
MELOXICAM 51 46* 12 29 117
PANTOPRAZOLE SODIUM 50 <11 <11 31 32
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.